Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure Disorder, Partial”

Showing 20 of 0 results

Not applicableUnknownNCT02089243
What this trial is testing

Controlled Randomized Vagus Nerve Stimulation (VNS) Therapy Versus Resection (CoRaVNStiR)

Who this might be right for
Epilepsy
Xijing Hospital 40
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Not applicableLooking for participantsNCT05339438
What this trial is testing

Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients

Who this might be right for
Epilepsy, Temporal LobeCognitive Decline
Central Hospital, Nancy, France 30
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Not applicableStudy completedNCT02844465
What this trial is testing

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Who this might be right for
Temporal Lobe Epilepsy
MedtronicNeuro 167
Not applicableStudy completedNCT03446664
What this trial is testing

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Who this might be right for
Epilepsies, PartialEpilepsy, Tonic-Clonic
LivaNova 33
Large-scale testing (Phase 3)Study completedNCT00113165
What this trial is testing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Who this might be right for
EpilepsyEpilepsy, Partial
GlaxoSmithKline 244
Large-scale testing (Phase 3)Study completedNCT00700310
What this trial is testing

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Who this might be right for
Refractory Partial Seizures
Eisai Inc. 712
Not applicableStudy completedNCT00567268
What this trial is testing

Drug Use Investigation Of Gabapentin

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,273
Testing effectiveness (Phase 2)Looking for participantsNCT06422923
What this trial is testing

NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Who this might be right for
Epilepsy, Temporal Lobe
Neurona Therapeutics 10
Not applicableLooking for participantsNCT06794606
What this trial is testing

Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies

Who this might be right for
Epilepsy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 337
Not applicableStudy completedNCT00922987
What this trial is testing

Clinical Study With Lyrica In Patients Suffering From Epilepsy

Who this might be right for
NeuralgiaEpilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 286
Not applicableStudy completedNCT00282854
What this trial is testing

Genetics of Rolandic Epilepsy

Who this might be right for
Epilepsy
King's College London 1,000
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Early research (Phase 1)Study completedNCT00233012
What this trial is testing

The Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Who this might be right for
Seizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 16
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Not applicableStudy completedNCT04169581
What this trial is testing

A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging

Who this might be right for
Epilepsy, Temporal Lobe
Second Affiliated Hospital, Zhejiang University, School of Medicine 201
Not applicableWithdrawnNCT02913742
What this trial is testing

The Utility of NIOM During LITT for Refractory MTLE

Who this might be right for
Epilepsy, Temporal Lobe
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT01496612
What this trial is testing

Buspirone Therapy for Localized Epilepsy

Who this might be right for
Anxiety DisorderSeizuresEpilepsy+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 9
Not applicableStudy completedNCT01587339
What this trial is testing

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

Who this might be right for
Epilepsy
GlaxoSmithKline 6,498
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation